Subclinical hypothyroidism - new cardiovascular risk factor


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

In last years there is discussion about subcLinicaL hypothyroidism (SHT) as a cardiovascular risk factor. We examined 870 patients with coronary artery disease. Height, weight, body mass index, thyroid-stimulating hormone level, lipid profile, homocysteine level were assessed in all patients. The presence of a history of arterial hypertension, diabetes mellitus type 2, and conducted therapy were considered. Elevation of thyroid-stimulating hormone level (so called SHT) has been associated with obesity, diabetes mellitus type 2, arterial hypertension, atherogenic dystipidemia, hyperhomocysteinemia. Multiple coronary lesion significantly higher revealed in patients with SHT. SHT was additional independent risk factor for coronary atherosclerosis.

Texto integral

Acesso é fechado

Sobre autores

Anna Volkova

Pavlov First Saint Petersburg state medical university

Email: volkovaa@mail.ru
PhD, associate professor of Department of faculty therapy

Svetlana Dora

Pavlov First Saint Petersburg state medical university

PhD, assistant professor of Department of faculty therapy

Olga Berkovich

Pavlov First Saint Petersburg state medical university

MD, professor, professor of Department of faculty therapy

Olga Dygun

Pavlov First Saint Petersburg state medical university

resident of Department of faculty therapy

Yelena Volkova

Pavlov First Saint Petersburg state medical university

PhD, associate professor of Department of faculty therapy

Yelena Ostroukhova

Pavlov First Saint Petersburg state medical university

PhD, associate professor of Department of faculty therapy

Bibliografia

  1. Rodondi N., Elzen W.P., Bauer D.C. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304(1):1365-74.
  2. Duntas L. H., Brenta G. The effect of thyroid disorders on lipid levels and metabolism. Med. Clin. North. Am. 2012;96(2):269-81.
  3. Deicher R., Vierhapper H. Homocysteine: a risk factor for cardiovascular disease in subclinical hypothyroidism? Thyroid. 2002;12(8):733-6.
  4. Петунина Н. А., Трухина Л.В. Гипотиреоз. Русский медицинский журнал. 2013; 12: 664-6. [Petunina N.A., Trukhina L.V. Hypothyroidism. RMJ. 2013;12:664-6. (in Russian)]
  5. Hernandez-Mijares A., Jover A., Bellod L., Banuls C., Sola E., Veses S., Victor V.M., Rocha M. Relation between lipoprotein subfractions and TSH levels in the cardiovascular risk among women with subclinical hypothyroidism. Clin. Endocrinol. 2013;78(5):777-82.
  6. Traub-Weidinger T., Graf S., Beheshti M., Ofluoglu S., Zettinig G., Khorsand A., Nekolla S.G., Kletter K., Dudczak R., Pirich C. Coronary vasoreactivity in subjects with thyroid autoimmunity and subclinical hypothyroidism before and after supplementation with thyroxine. Thyroid.2011;22(3):245-51.
  7. Duntas L. H., Biondi B. New insights into subclinical hypothyroidism and cardiovascular risk. Semin. Thromb. Hemost. 2011; 37(1): 27-34.
  8. Biondi B. Natural history, diagnosis and management of subclinical thyroid dysfunction. Best Pract. Res. Clin. Endocrinol. Metab. 2012;26(4):431-46.
  9. Hofman A., Darwish Murad S., van Duijn C.M., Franco O.H., Goedegebure A., Ikram M.A., Klaver C.C., Nijsten T.E., Peeters R.P., Stricker B.H., Tiemeier H.W., Uitterlinden A.G., Vernooij M.W. The Rotterdam Study: 2014 objectives and design update. Eur. J. Epidemiol. 2013; 28(111:889-926.
  10. Фадеев В.В. Современные принципы диагностики и лечения гипотиреоза. Медицинский совет. 2013; 4: 76-81. [Fadeyev V.V. Principles of diagnosis and treatment of hypothyroidism today. Medical council. 2013;4:76-81 (in Russian)]
  11. Baloch Z., Carayon P., Conte-Devolx B., Demers L.M., Feldt-Rasmussen U., Henry J.F., LiVosli V.A., Niccoli-Sire P., John R., Ruf J., Smyth P.P., Spencer C.A., Stockigt J.R. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003;13(1): 3-126.
  12. Некрасова Т.А., Стронгин Л.Г., Леденцова О.В., Казакова Л.В. Взаимосвязь между уровнем ТТГ и некоторыми факторами сердечно-сосудистого риска при аутоиммунном тиреоидите и субклиническом гипотиреозе. Клиническая и экспериментальная тиреоидология. 2014; 10 (2): 16-21. [Nekrasova T.A., Strongin L.G., Ledentsova O.V., Kasakova L.V. Relationship between TSH values and cardiovascular risk factors in patients with autoimmune thyroiditis and subclinical hypothyroidism. Clinical and experimental thyroidology. 2014;10(2):16-21 (in Russian)]
  13. Фадеев В.В. По материалам клинических рекомендаций Американской ассоциации клинических эндокринологов и Американской тиреоидной ассоциации по диагностике и лечению гипотиреоза у взрослых. Клиническая и экспериментальная тиреоидология. 2012;8(3):1-8. [Fadeev V.V. Clinical practice guidelines for hypothyroidism in adults: co-sponsored by American association of clinical endocrinologists and American thyroid association. Clinical and experimental thyroidology. 2012 ;8(3) :1 -8 (in Russian)]

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2016

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies